<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2023//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_230101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="MEDLINE" Owner="NLM" IndexingMethod="Automated"><PMID Version="1">36797549</PMID><DateCompleted><Year>2023</Year><Month>05</Month><Day>24</Day></DateCompleted><DateRevised><Year>2023</Year><Month>05</Month><Day>24</Day></DateRevised><Article PubModel="Print-Electronic"><Journal><ISSN IssnType="Electronic">1434-9949</ISSN><JournalIssue CitedMedium="Internet"><Volume>42</Volume><Issue>6</Issue><PubDate><Year>2023</Year><Month>Jun</Month></PubDate></JournalIssue><Title>Clinical rheumatology</Title><ISOAbbreviation>Clin Rheumatol</ISOAbbreviation></Journal><ArticleTitle>Infection in systemic lupus erythematosus-associated diffuse alveolar hemorrhage: a potential key to improve outcomes.</ArticleTitle><Pagination><StartPage>1573</StartPage><EndPage>1584</EndPage><MedlinePgn>1573-1584</MedlinePgn></Pagination><ELocationID EIdType="doi" ValidYN="Y">10.1007/s10067-023-06517-8</ELocationID><Abstract><AbstractText Label="OBJECTIVES" NlmCategory="OBJECTIVE">This study aimed to investigate the clinical characteristics, outcomes, and associated factors of patients with systemic lupus erythematosus-associated diffusive alveolar hemorrhage (SLE-DAH) stratified by infection status in a national representative cohort.</AbstractText><AbstractText Label="METHODS" NlmCategory="METHODS">This single-center retrospective study included 124 consecutive patients with SLE-DAH in a tertiary care center between 2006 and 2021. The diagnosis of DAH was made based on a comprehensive evaluation of clinical manifestations, laboratory and radiologic findings, and bronchoalveolar lavage. Demographics, clinical features, and survival curves were compared between patients with bacterial, non-bacterial, and non-infection groups. Univariate and multivariate logistic regression analyses were performed to determine the factors independently associated with bacterial infection in SLE-DAH.</AbstractText><AbstractText Label="RESULTS" NlmCategory="RESULTS">Fifty-eight patients with SLE-DAH developed bacterial infection after DAH occurrence, thirty-two patients developed fungal and/or viral infection, and thirty-four patients were categorized as non-infection. The bacterial infection group have a worse prognosis (OR 3.059, 95%CI 1.469-6.369, p&#x2009;=&#x2009;0.002) compared with the other two groups, with a mortality rate of 60.3% within 180&#xa0;days after DAH occurrence. Factors independently associated with bacterial infections in SLE-DAH included hematuria (OR 4.523, 95%CI 1.068-19.155, p&#x2009;=&#x2009;0.040), hemoglobin drop in the first 24&#xa0;h after DAH occurred (OR 1.056, 95%CI 1.001-1.115, p&#x2009;=&#x2009;0.049), and anti-Smith antibody (OR 0.167, 95%CI 0.052-0.535, p&#x2009;=&#x2009;0.003). Glucocorticoid pulse therapy and cyclophosphamide were administered in more than 50% of patients regardless of their infectious status. According to clinical experience at our hospital and in previous studies, we recommended a comprehensive management algorithm for SLE-DAH based on infection stratification.</AbstractText><AbstractText Label="CONCLUSION" NlmCategory="CONCLUSIONS">Infection, especially bacterial infection, is a severe complication and prognostic factor of SLE-DAH. Comprehensive management strategies, including diagnosis, evaluation, treatment, and monitoring, based on infection stratification may fundamentally improve outcomes of patients with SLE-DAH. Key Points &#x2022; Bacterial infection is an important, but neglected, prognosis factor of systemic lupus erythematosus (SLE)-associated diffusive alveolar hemorrhage (DAH). &#x2022; Hematuria, hemoglobin drop, and anti-Smith antibody can independently predict bacterial infections in SLE-DAH. &#x2022; We put forward a comprehensive management algorithm based on infection stratification for SLE-DAH.</AbstractText><CopyrightInformation>&#xa9; 2023. The Author(s), under exclusive licence to International League of Associations for Rheumatology (ILAR).</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Mucong</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science &amp; Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bai</LastName><ForeName>Wei</ForeName><Initials>W</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science &amp; Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wang</LastName><ForeName>Yanhong</ForeName><Initials>Y</Initials><AffiliationInfo><Affiliation>Department of Epidemiology and Biostatistics, Institute of Basic Medical Sciences Chinese Academy of Medical Sciences, School of Basic Medicine Peking, Union Medical College, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Song</LastName><ForeName>Lan</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Department of Radiology, Peking Union Medical College Hospital, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhang</LastName><ForeName>Shangzhu</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science &amp; Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zhao</LastName><ForeName>Jiuliang</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science &amp; Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Wu</LastName><ForeName>Chanyuan</ForeName><Initials>C</Initials><Identifier Source="ORCID">0000-0003-2710-9359</Identifier><AffiliationInfo><Affiliation>Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science &amp; Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, 100730, China. wucy@pumch.cn.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Li</LastName><ForeName>Mengtao</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science &amp; Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tian</LastName><ForeName>Xinping</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science &amp; Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zeng</LastName><ForeName>Xiaofeng</ForeName><Initials>X</Initials><AffiliationInfo><Affiliation>Department of Rheumatology and Clinical Immunology, Chinese Academy of Medical Sciences &amp; Peking Union Medical College, National Clinical Research Center for Dermatologic and Immunologic Diseases (NCRC-DID), Ministry of Science &amp; Technology, State Key Laboratory of Complex Severe and Rare Diseases, Peking Union Medical College Hospital (PUMCH), Key Laboratory of Rheumatology and Clinical Immunology, Ministry of Education, Beijing, 100730, China.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><GrantList CompleteYN="Y"><Grant><GrantID>2021YFC2501301-5</GrantID><Agency>Chinese National Key Technology R&amp;D Program, Ministry of Science and Technology</Agency><Country/></Grant><Grant><GrantID>2017YFC0907601-3</GrantID><Agency>Chinese National Key Technology R&amp;D Program, Ministry of Science and Technology</Agency><Country/></Grant><Grant><GrantID>No.Z201100005520022</GrantID><Agency>Beijing Municipal Science &amp; Technology Commission</Agency><Country/></Grant><Grant><GrantID>23</GrantID><Agency>Beijing Municipal Science &amp; Technology Commission</Agency><Country/></Grant><Grant><GrantID>25-27</GrantID><Agency>Beijing Municipal Science &amp; Technology Commission</Agency><Country/></Grant><Grant><GrantID>2021-I2M-1-005</GrantID><Agency>CAMS Innovation Fund for Medical Sciences (CIFMS)</Agency><Country/></Grant></GrantList><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>02</Month><Day>17</Day></ArticleDate></Article><MedlineJournalInfo><Country>Germany</Country><MedlineTA>Clin Rheumatol</MedlineTA><NlmUniqueID>8211469</NlmUniqueID><ISSNLinking>0770-3198</ISSNLinking></MedlineJournalInfo><ChemicalList><Chemical><RegistryNumber>0</RegistryNumber><NameOfSubstance UI="D006454">Hemoglobins</NameOfSubstance></Chemical></ChemicalList><CitationSubset>IM</CitationSubset><MeshHeadingList><MeshHeading><DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D012189" MajorTopicYN="N">Retrospective Studies</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D006417" MajorTopicYN="N">Hematuria</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D011650" MajorTopicYN="N">Pulmonary Alveoli</DescriptorName></MeshHeading><MeshHeading><DescriptorName UI="D008180" MajorTopicYN="Y">Lupus Erythematosus, Systemic</DescriptorName><QualifierName UI="Q000150" MajorTopicYN="N">complications</QualifierName><QualifierName UI="Q000188" MajorTopicYN="N">drug therapy</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006470" MajorTopicYN="N">Hemorrhage</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D008171" MajorTopicYN="Y">Lung Diseases</DescriptorName><QualifierName UI="Q000209" MajorTopicYN="N">etiology</QualifierName><QualifierName UI="Q000175" MajorTopicYN="N">diagnosis</QualifierName></MeshHeading><MeshHeading><DescriptorName UI="D006454" MajorTopicYN="N">Hemoglobins</DescriptorName></MeshHeading></MeshHeadingList><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">Bacterial infections</Keyword><Keyword MajorTopicYN="N">Diffusive alveolar hemorrhage</Keyword><Keyword MajorTopicYN="N">Systemic lupus erythematosus</Keyword></KeywordList></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2022</Year><Month>8</Month><Day>29</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>1</Month><Day>17</Day></PubMedPubDate><PubMedPubDate PubStatus="revised"><Year>2022</Year><Month>12</Month><Day>21</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>5</Month><Day>24</Day><Hour>6</Hour><Minute>42</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>2</Month><Day>17</Day><Hour>6</Hour><Minute>0</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>2</Month><Day>16</Day><Hour>23</Hour><Minute>30</Minute></PubMedPubDate></History><PublicationStatus>ppublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">36797549</ArticleId><ArticleId IdType="doi">10.1007/s10067-023-06517-8</ArticleId><ArticleId IdType="pii">10.1007/s10067-023-06517-8</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Narv&#xe1;ez J, Borrell H, S&#xe1;nchez-Alonso F et al (2018) Primary respiratory disease in patients with systemic lupus erythematosus: data from the Spanish rheumatology society lupus registry (RELESSER) cohort. Arthritis Res Ther 20:280. https://doi.org/10.1186/s13075-018-1776-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-018-1776-8</ArticleId><ArticleId IdType="pubmed">30567600</ArticleId><ArticleId IdType="pmc">6299951</ArticleId></ArticleIdList></Reference><Reference><Citation>Kim D, Choi J, Cho S-K et al (2017) Clinical characteristics and outcomes of diffuse alveolar hemorrhage in patients with systemic lupus erythematosus. Semin Arthritis Rheum 46:782&#x2013;787. https://doi.org/10.1016/j.semarthrit.2016.09.004</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2016.09.004</ArticleId><ArticleId IdType="pubmed">27745903</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Mart&#xed;nez MU, Abud-Mendoza C (2011) Predictors of mortality in diffuse alveolar haemorrhage associated with systemic lupus erythematosus. Lupus 20:568&#x2013;574. https://doi.org/10.1177/0961203310392430</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203310392430</ArticleId><ArticleId IdType="pubmed">21558137</ArticleId></ArticleIdList></Reference><Reference><Citation>Chang MY, Fang JT, Chen YC et al (2002) Diffuse alveolar hemorrhage in systemic lupus erythematosus: a single center retrospective study in Taiwan. Ren Fail 24:791&#x2013;802. https://doi.org/10.1081/jdi-120015681</Citation><ArticleIdList><ArticleId IdType="doi">10.1081/jdi-120015681</ArticleId><ArticleId IdType="pubmed">12472201</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Mart&#xed;nez MU, Abud-Mendoza C (2014) Hemorragia alveolar difusa en pacientes con lupus eritematoso sist&#xe9;mico. Manifestaciones cl&#xed;nicas, tratamiento y pron&#xf3;stico. Reumatol Cl&#xed;n 10:248&#x2013;253. https://doi.org/10.1016/j.reuma.2014.02.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.reuma.2014.02.002</ArticleId><ArticleId IdType="pubmed">24704107</ArticleId></ArticleIdList></Reference><Reference><Citation>Zamora MR, Warner ML, Tuder R et al (1997) Diffuse alveolar hemorrhage and systemic lupus erythematosus. Clinical presentation, histology, survival, and outcome. Medicine (Baltimore) 76:192&#x2013;202. https://doi.org/10.1097/00005792-199705000-00005</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/00005792-199705000-00005</ArticleId><ArticleId IdType="pubmed">9193454</ArticleId></ArticleIdList></Reference><Reference><Citation>Badsha H, Teh CL, Kong KO et al (2004) Pulmonary hemorrhage in systemic lupus erythematosus. Semin Arthritis Rheum 33:414&#x2013;421. https://doi.org/10.1016/j.semarthrit.2003.09.006</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.semarthrit.2003.09.006</ArticleId><ArticleId IdType="pubmed">15190526</ArticleId></ArticleIdList></Reference><Reference><Citation>Moreno-Torres V, Mart&#xed;nez-Urbistondo M, Guti&#xe9;rrez-Rojas A et al (2022) Impact of severe infections in SLE: an observational study from the Spanish national registry. Lupus Sci Med 9:e000711. https://doi.org/10.1136/lupus-2022-000711</Citation></Reference><Reference><Citation>Yurkovich M, Vostretsova K, Chen W et al (2014) Overall and cause-specific mortality in patients with systemic lupus erythematosus: a meta-analysis of observational studies. Arthritis Care Res (Hoboken) 66:608&#x2013;616. https://doi.org/10.1002/acr.22173</Citation><ArticleIdList><ArticleId IdType="doi">10.1002/acr.22173</ArticleId><ArticleId IdType="pubmed">24106157</ArticleId></ArticleIdList></Reference><Reference><Citation>Yang Y, Jiang H, Wang C et al (2021) Clinical Characteristics and prognoses of patients with systemic lupus erythematosus hospitalized for pulmonary infections. Front Med (Lausanne) 8:732681. https://doi.org/10.3389/fmed.2021.732681</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.732681</ArticleId><ArticleId IdType="pubmed">34660641</ArticleId></ArticleIdList></Reference><Reference><Citation>Jiang M, Chen R, Zhao L et al (2021) Risk factors for mortality of diffuse alveolar hemorrhage in systemic lupus erythematosus: a systematic review and meta-analysis. Arthritis Res Ther 23:57. https://doi.org/10.1186/s13075-021-02435-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13075-021-02435-9</ArticleId><ArticleId IdType="pubmed">33593433</ArticleId><ArticleId IdType="pmc">7885396</ArticleId></ArticleIdList></Reference><Reference><Citation>Mirouse A, Parrot A, Audigier V et al (2020) Severe diffuse alveolar hemorrhage related to autoimmune disease: a multicenter study. Crit Care 24:231. https://doi.org/10.1186/s13054-020-02936-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13054-020-02936-0</ArticleId><ArticleId IdType="pubmed">32423434</ArticleId><ArticleId IdType="pmc">7236262</ArticleId></ArticleIdList></Reference><Reference><Citation>Sun Y, Zhou C, Zhao J et al (2020) Systemic lupus erythematosus-associated diffuse alveolar hemorrhage: a single-center, matched case-control study in China. Lupus 29:795&#x2013;803. https://doi.org/10.1177/0961203320920715</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203320920715</ArticleId><ArticleId IdType="pubmed">32321345</ArticleId></ArticleIdList></Reference><Reference><Citation>Bhushan A, Choi D, Maresh G et al (2021) Risk factors and outcomes of immune and non-immune causes of diffuse alveolar hemorrhage: a tertiary-care academic single-center experience. Rheumatol Int. https://doi.org/10.1007/s00296-021-04842-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00296-021-04842-2</ArticleId><ArticleId IdType="pubmed">33782747</ArticleId></ArticleIdList></Reference><Reference><Citation>Papazian L, Klompas M, Luyt C-E (2020) Ventilator-associated pneumonia in adults: a narrative review. Intensive Care Med 46:888&#x2013;906. https://doi.org/10.1007/s00134-020-05980-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-05980-0</ArticleId><ArticleId IdType="pubmed">32157357</ArticleId><ArticleId IdType="pmc">7095206</ArticleId></ArticleIdList></Reference><Reference><Citation>Kwok SK, Moon SJ, Ju JH et al (2011) Diffuse alveolar hemorrhage in systemic lupus erythematosus: risk factors and clinical outcome: results from affiliated hospitals of Catholic University of Korea. Lupus 20:102&#x2013;107. https://doi.org/10.1177/0961203310381511</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203310381511</ArticleId><ArticleId IdType="pubmed">20956464</ArticleId></ArticleIdList></Reference><Reference><Citation>Martinez-Martinez MU, Sturbaum AK, Alcocer-Varela J et al (2014) Factors associated with mortality and infections in patients with systemic lupus erythematosus with diffuse alveolar hemorrhage. J Rheumatol 41:1656&#x2013;1661. https://doi.org/10.3899/jrheum.130927</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.130927</ArticleId><ArticleId IdType="pubmed">24986849</ArticleId></ArticleIdList></Reference><Reference><Citation>di Pasquale M, Ferrer M, Esperatti M et al (2014) Assessment of severity of ICU-acquired pneumonia and association with etiology. Crit Care Med 42:303&#x2013;312. https://doi.org/10.1097/CCM.0b013e3182a272a2</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/CCM.0b013e3182a272a2</ArticleId><ArticleId IdType="pubmed">23989176</ArticleId></ArticleIdList></Reference><Reference><Citation>Rello J, Ollendorf DA, Oster G et al (2002) Epidemiology and outcomes of ventilator-associated pneumonia in a large US database. Chest 122:2115&#x2013;2121. https://doi.org/10.1378/chest.122.6.2115</Citation><ArticleIdList><ArticleId IdType="doi">10.1378/chest.122.6.2115</ArticleId><ArticleId IdType="pubmed">12475855</ArticleId></ArticleIdList></Reference><Reference><Citation>Bailey KL, Kalil AC (2015) Ventilator-associated pneumonia (VAP) with multidrug-resistant (MDR) pathogens: optimal treatment? Curr Infect Dis Rep 17:494. https://doi.org/10.1007/s11908-015-0494-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11908-015-0494-5</ArticleId><ArticleId IdType="pubmed">26092246</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Jiao Y, Zhang J et al (2018) Microbial etiology and prognostic factors of ventilator-associated pneumonia: a multicenter retrospective study in Shanghai. Clin Infect Dis 67:S146-s152. https://doi.org/10.1093/cid/ciy686</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/cid/ciy686</ArticleId><ArticleId IdType="pubmed">30423049</ArticleId></ArticleIdList></Reference><Reference><Citation>Luyt CE, H&#xe9;kimian G, Koulenti D et al (2018) Microbial cause of ICU-acquired pneumonia: hospital-acquired pneumonia versus ventilator-associated pneumonia. Curr Opin Crit Care 24:332&#x2013;338. https://doi.org/10.1097/mcc.0000000000000526</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/mcc.0000000000000526</ArticleId><ArticleId IdType="pubmed">30036192</ArticleId></ArticleIdList></Reference><Reference><Citation>Danza A, Ruiz-Irastorza G (2013) Infection risk in systemic lupus erythematosus patients: susceptibility factors and preventive strategies. Lupus 22:1286&#x2013;1294. https://doi.org/10.1177/0961203313493032</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203313493032</ArticleId><ArticleId IdType="pubmed">24098001</ArticleId></ArticleIdList></Reference><Reference><Citation>Shen M, Zeng X, Tian X et al (2010) Diffuse alveolar hemorrhage in systemic lupus erythematosus: a retrospective study in China. Lupus 19:1326&#x2013;1330. https://doi.org/10.1177/0961203310373106</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203310373106</ArticleId><ArticleId IdType="pubmed">20647253</ArticleId></ArticleIdList></Reference><Reference><Citation>Hughson MD, He Z, Henegar J et al (2001) Alveolar hemorrhage and renal microangiopathy in systemic lupus erythematosus. Arch Pathol Lab Med 125:475&#x2013;483. https://doi.org/10.5858/2001-125-0475-aharmi</Citation><ArticleIdList><ArticleId IdType="doi">10.5858/2001-125-0475-aharmi</ArticleId><ArticleId IdType="pubmed">11260619</ArticleId></ArticleIdList></Reference><Reference><Citation>Merola JF, Prystowsky SD, Iversen C et al (2013) Association of discoid lupus erythematosus with other clinical manifestations among patients with systemic lupus erythematosus. J Am Acad Dermatol 69:19&#x2013;24. https://doi.org/10.1016/j.jaad.2013.02.010</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jaad.2013.02.010</ArticleId><ArticleId IdType="pubmed">23541758</ArticleId><ArticleId IdType="pmc">3686921</ArticleId></ArticleIdList></Reference><Reference><Citation>Li PH, Wong WH, Lee TL et al (2013) Relationship between autoantibody clustering and clinical subsets in SLE: cluster and association analyses in Hong Kong Chinese. Rheumatology (Oxford) 52:337&#x2013;345. https://doi.org/10.1093/rheumatology/kes261</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/kes261</ArticleId><ArticleId IdType="pubmed">23038697</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhao K, Xie H, Li L et al (2021) Increased risk of severe infections and mortality in patients with newly diagnosed systemic lupus erythematosus: a population-based study. Rheumatology (Oxford) 60:5300&#x2013;5309. https://doi.org/10.1093/rheumatology/keab219</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/rheumatology/keab219</ArticleId><ArticleId IdType="pubmed">33751035</ArticleId></ArticleIdList></Reference><Reference><Citation>Alexandre AT, Vale A, Gomes T (2019) Diffuse alveolar hemorrhage: how relevant is etiology? Sarcoidosis Vasc Diffuse Lung Dis 36:47&#x2013;52. https://doi.org/10.36141/svdld.v36i1.7160</Citation><ArticleIdList><ArticleId IdType="doi">10.36141/svdld.v36i1.7160</ArticleId><ArticleId IdType="pubmed">32476936</ArticleId><ArticleId IdType="pmc">7247111</ArticleId></ArticleIdList></Reference><Reference><Citation>Lichtenberger JP, Digumarthy SR, Abbott GF et al (2014) Diffuse pulmonary hemorrhage: clues to the diagnosis. Curr Probl Diagn Radiol 43:128&#x2013;139. https://doi.org/10.1067/j.cpradiol.2014.01.002</Citation><ArticleIdList><ArticleId IdType="doi">10.1067/j.cpradiol.2014.01.002</ArticleId><ArticleId IdType="pubmed">24791616</ArticleId></ArticleIdList></Reference><Reference><Citation>Andrade C, Mendon&#xe7;a T, Farinha F et al (2016) Alveolar hemorrhage in systemic lupus erythematosus: a cohort review. Lupus 25:75&#x2013;80. https://doi.org/10.1177/0961203315605365</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/0961203315605365</ArticleId><ArticleId IdType="pubmed">26385219</ArticleId></ArticleIdList></Reference><Reference><Citation>Mart&#xed;nez-Mart&#xed;nez MU, Oostdam DAH, Abud-Mendoza C (2017) Diffuse alveolar hemorrhage in autoimmune diseases. Curr Rheumatol Rep 19:27. https://doi.org/10.1007/s11926-017-0651-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11926-017-0651-y</ArticleId><ArticleId IdType="pubmed">28397125</ArticleId></ArticleIdList></Reference><Reference><Citation>Barile LA, Jara LJ, Medina-Rodriguez F et al (1997) Pulmonary hemorrhage in systemic lupus erythematosus. Lupus 6:445&#x2013;448. https://doi.org/10.1177/096120339700600506</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/096120339700600506</ArticleId><ArticleId IdType="pubmed">9229363</ArticleId></ArticleIdList></Reference><Reference><Citation>Ednalino C, Yip J, Carsons SE (2015) Systematic review of diffuse alveolar hemorrhage in systemic lupus erythematosus: focus on outcome and therapy. J Clin Rheumatol 21:305&#x2013;310. https://doi.org/10.1097/rhu.0000000000000291</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/rhu.0000000000000291</ArticleId><ArticleId IdType="pubmed">26308350</ArticleId></ArticleIdList></Reference><Reference><Citation>Rathi NK, Tanner AR, Dinh A et al (2015) Low-, medium- and high-dose steroids with or without aminocaproic acid in adult hematopoietic SCT patients with diffuse alveolar hemorrhage. Bone Marrow Transplant 50:420&#x2013;426. https://doi.org/10.1038/bmt.2014.287</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/bmt.2014.287</ArticleId><ArticleId IdType="pubmed">25531284</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres A, Niederman MS, Chastre J et al (2017) International ERS/ESICM/ESCMID/ALAT guidelines for the management of hospital-acquired pneumonia and ventilator-associated pneumonia: Guidelines for the management of hospital-acquired pneumonia (HAP)/ventilator-associated pneumonia (VAP) of the European Respiratory Society (ERS), European Society of Intensive Care Medicine (ESICM), European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and Asociaci&#xf3;n Latinoamericana del T&#xf3;rax (ALAT). Eur Respir J 50:1700582. https://doi.org/10.1183/13993003.00582-2017</Citation></Reference><Reference><Citation>Kazzaz NM, Coit P, Lewis EE et al (2015) Systemic lupus erythematosus complicated by diffuse alveolar haemorrhage: risk factors, therapy and survival. Lupus Science &amp; Medicine 2:e000117. https://doi.org/10.1136/lupus-2015-000117</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/lupus-2015-000117</ArticleId></ArticleIdList></Reference><Reference><Citation>Blay G, Rodrigues JC, Ferreira JCO et al (2018) Diffuse alveolar hemorrhage in childhood-onset systemic lupus erythematosus: a severe disease flare with serious outcome. Adv Rheumatol 58:39. https://doi.org/10.1186/s42358-018-0038-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s42358-018-0038-4</ArticleId><ArticleId IdType="pubmed">30657099</ArticleId></ArticleIdList></Reference><Reference><Citation>Rajagopala S, Sagar BK, Thabah MM et al (2015) Pulmonary-renal syndromes: experience from an Indian intensive care unit. Indian J Crit Care Med 19:316&#x2013;325. https://doi.org/10.4103/0972-5229.158261</Citation><ArticleIdList><ArticleId IdType="doi">10.4103/0972-5229.158261</ArticleId><ArticleId IdType="pubmed">26195857</ArticleId><ArticleId IdType="pmc">4478672</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>